S-OA-L Oral Abstracts - Session L - Allogeneic Transplants

Track: BMT Tandem "Scientific" Meeting
Saturday, February 16, 2013: 4:45 PM-6:45 PM
Ballroom A-D (Salt Palace Convention Center)
Chairs:
Leo Luznik, MD and Steve Mackinnon
Summary:

Abstracts: #2535, 2284, 2475, 2714, 2287, 2628, 2364, 2298

13
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Sameh Gaballa, MD, Kimmel Cancer Center, Thomas Jefferson University; Onder Alpdogan, MD, Kimmel Cancer Center, Thomas Jefferson University; Matthew Carabasi, MD, Kimmel Cancer Center, Thomas Jefferson University; Joanne Filicko, MD, Kimmel Cancer Center, Thomas Jefferson University; Margaret Kasner, MD, Kimmel Cancer Center, Thomas Jefferson University; Ubaldo Martinez, MD, Kimmel Cancer Center, Thomas Jefferson University; John L. Wagner, MD, Kimmel Cancer Center, Thomas Jefferson University; Mark Weiss, MD, Kimmel Cancer Center, Thomas Jefferson University; Neal Flomenberg, MD, Kimmel Cancer Center, Thomas Jefferson University; Dolores Grosso, DNP, Kimmel Cancer Center, Thomas Jefferson University

23
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Joanne Kurtzberg, MD, Duke University Medical Center; Shelly L Carter, ScD, The EMMES Corporation; Adam Mendizabal, MS, The EMMES Corporation; Donna A Wall, MD, CancerCare Manitoba; Kirk R. Schultz, BC Childrens Hospital; Nancy A Kernan, MD, Memorial Sloan-Kettering Cancer Ctr; Mary Eapen, MD, MS, Medical College of Wisconsin; John E. Wagner, MD, University of Minnesota

26
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Maria Teresa Lupo Stanghellini, MD, San Raffaele Scientific Institute; Sara Mastaglio, MD, San Raffaele Scientific Institute; Matteo Carrabba, MD, San Raffaele Scientific Institute; Elisa Sala, MD, San Raffaele Scientific Institute; Magda Marcatti, MD, San Raffaele Scientific Institute; Andrea Assanelli, MD, San Raffaele Scientific Institute; Michela Tassara, MD, San Raffaele Scientific Institute; Carlo Messina, MD, San Raffaele Scientific Institute; Katharina Fleischhauer, MD, San Raffaele Scientific Institute; Elena Guggiari, MD, San Raffaele Scientific Institute; Sarah Marktel, MD, San Raffaele Scientific Institute; Francesca Lunghi, MD, San Raffaele Scientific Institute; Salvatore Gattillo, MD, San Raffaele Scientific Institute; Laura Bellio, MD, San Raffaele Scientific Institute; Milena Coppola, MD, San Raffaele Scientific Institute; Maria Chiara Bonini, MD, San Raffaele Scientific Institute; Claudio Bordignon, MD, San Raffaele Scientific Institute; Consuelo Corti, MD, San Raffaele Scientific Institute; Iacopo Peccatori, MD, San Raffaele Scientific Institute; Massimo Bernardi, MD, San Raffaele Scientific Institute; Fabio Ciceri, MD, San Raffaele Scientific Institute

29
Outcomes of Allogeneic HSCT for Patients with Hematologic Malignancies (AML, ALL, MDS, CML) with and without Pre-Existing Fungal Infections: A Cibmtr Study
Richard T. Maziarz, MD, Oregon Health and Science University; Aleksandra McLeod, MD, Oregon Health & Science University; Min Chen, Medical College of Wisconsin; Juan Gea-Banacloche, MD, NCI; Paul Szabolcs, MD, University of Pittsburgh; Michael J. Boeckh, MD, Fred Hutchinson Cancer Research Center; Marcie Tomblyn, MD, MS, H. Lee Moffitt Cancer Center

30
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Amanda L. Olson, MD, Memorial Sloan-Kettering Cancer Center; Parastoo Dahi, MD, Memorial Sloan-Kettering Cancer Center; Junting Zheng, MS, Memorial Sloan-Kettering Cancer Center; Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center; Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center; Anne Marie Gonzales, BS, Memorial Sloan-Kettering Cancer Center; Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center; Doris Ponce, MD, Memorial Sloan-Kettering Cancer Center; Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center; Andromachi Scaradavou, Memorial Sloan-Kettering Cancer Center; Genovefa Papanicolaou, MD, Memorial Sloan-Kettering Cancer Center; Juliet N. Barker, MBBS, (Hons), FRACP, Memorial Sloan-Kettering Cancer Center

31
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Simrit Parmar, MD, UT MD Anderson Cancer Center; Josh Howell, UT MD Anderson Cancer Center; Michael Wang, UT MD Anderson Cancer Center; Mubeen Khan, UT MD Anderson Cancer Center; Qaiser Bashir, MD, UT MD Anderson Cancer Center; Nina Shah, MD, UT MD Anderson Cancer Center; Jatin Shah, UT MD Anderson Cancer Center; Uday Popat, MD, UT MD Anderson Cancer Center; Yvonne Dinh, BS, UT MD Anderson Cancer Center; Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center; Richard E. Champlin, MD, MD Anderson Cancer Center; Robert Orlowski, UT MD Anderson Cancer Center; Muzaffar Qazilbash, MD, UT MD Anderson Cancer Center

33
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Luciana Tucunduva, MD, Eurocord International Registry, Paris, France; Annalisa Ruggeri, MD, Eurocord International Registry, Paris, France; Guillermo Sanz, MD, Hospital Univ. La Fe; Sabine Furst, MD, Institut Paoli Calmettes; Bernard Rio, MD, Hotel Dieu; Gerard Socié, MD, PhD, Hospital Saint Louis; William Arcese, MD, University; Mauricette Michallet, MD, Hopital Edouard Herriot, CHRU Lyon; Ibrahim Yakoub-Agha, MD, PhD, CHU de Lille; Jan Cornelissen, MD, PhD, Dr. Daniel Den Hoed Cancer Center; Miguel A. Sanz, MD, PhD, Hospital Universitario La Fe; Pau Montesinos, MD, Hospital U. La Fe; Duncan Purtill, Eurocord International Registry, Paris, France; Eliane Gluckman, MD RFCP, Eurocord; Vanderson Rocha, MD, PhD, Eurocord

35
Incidence and Kinetics of CMV Infection After T-Cell Depleted and Unmodified Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience At Memorial Sloan-Kettering Cancer Center
Kun Xiao, MD MPH, Memorial Sloan-Kettering Cancer Center; Ubonvan Jongwutiwes, MD, Memorial Sloan-Kettering Cancer Center; Dick Chung, Memorial Sloan-Kettering Cancer Center; Ann A. Jakubowski, PhD MD, Memorial Sloan-Kettering Cancer Center; Genovefa Papanicolaou, MD, Memorial Sloan-Kettering Cancer Center